News

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Dose optimization and RP2D determination on schedule for completion in Q4 2025 for the Nectin-4 ADC CRB-701 in HNSCC, ...